Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Marginal zone B cells - % of B2 cells
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total T cells - % of CD45+
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average branch length of vg5+ DETC contacting LC
|
WIL
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average branch length of vg5+ DETC contacting LC
|
HET
|
2f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Organ Weight / Spleen weight
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.175
|
Successful |
Nxnem1(IMPC)Bay
|
BCM
|
Organ Weight / Spleen weight
|
HET
|
5f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.594
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Organ Weight / Spleen weight
|
HET
|
5f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.655
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Organ Weight / Spleen weight
|
HET
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.763
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average roundness of vg5+ DETC contacting LC
|
WIL
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average roundness of vg5+ DETC contacting LC
|
HET
|
2f:m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Immunoglobulin / IgM
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / B cell number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / B cell number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / CD8+ T cells - % of live leukocytes (Panel A)
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0114
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Granulocytes - % of myeloid cells
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / CD8 T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NKT cell number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NKT cell number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pre-pro B cells (Hardy fraction A) - % of B220+
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ NK cells - % of NK cells
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Naive CD8+ T cells - % of CD8+
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Hematology / Mean cell hemoglobin concentration
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxnem1(IMPC)J
|
JAX
|
Hematology / Mean cell hemoglobin concentration
|
HET
|
5f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
1.28×10-05
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Hematology / Mean cell hemoglobin concentration
|
HET
|
5f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00831
|
Successful |
Nxnem1(IMPC)Bay
|
BCM
|
Hematology / Mean cell hemoglobin concentration
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0517
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Hematology / Mean cell hemoglobin concentration
|
HET
|
7f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.0786
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Hematology / Mean cell hemoglobin concentration
|
HET
|
6f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.110
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Hematology / Mean cell hemoglobin concentration
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.241
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Hematology / Mean cell hemoglobin concentration
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.373
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Hematology / Mean cell hemoglobin concentration
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.584
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Hematology / Mean cell hemoglobin concentration
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.654
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Hematology / Mean cell hemoglobin concentration
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.685
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Hematology / Mean cell hemoglobin concentration
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.713
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Mean cell hemoglobin concentration
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.946
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Hematology / Mean cell hemoglobin concentration
|
HET
|
4f:3m
|
Linear Mixed Model framework, LME, including Weight
|
0.992
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Hematology / Mean cell hemoglobin concentration
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
FACS / B2 Immature + MZB
|
HET
|
4f:4m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4+ T helper cells - % of CD4+ T helper cells
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD4- NKT cells - % of CD4- NKT cells
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
FACS / Monocytes
|
HET
|
4f:4m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / Eosinophils
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / Eosinophils
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / Eosinophils - % of live leukocytes (Panel B)
|
HET
|
7f:8m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total myeloid cells - % of CD45+
|
HET
|
1f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / DN CD44+CD62L- T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total B cells - % of CD45+
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Hematology / Mean platelet volume
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.000192
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Hematology / Mean platelet volume
|
HET
|
7f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.157
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Hematology / Mean platelet volume
|
HET
|
5f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.210
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Hematology / Mean platelet volume
|
HET
|
4f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.320
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Hematology / Mean platelet volume
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.374
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Hematology / Mean platelet volume
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.688
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Hematology / Mean platelet volume
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.859
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Hematology / Mean platelet volume
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.954
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Hematology / Eosinophil differential count
|
HET
|
7f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0806
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Hematology / Eosinophil differential count
|
HET
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0970
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Hematology / Eosinophil differential count
|
HET
|
8f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.178
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Eosinophil differential count
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.410
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Hematology / Eosinophil differential count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.444
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Hematology / Eosinophil differential count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.590
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Hematology / Eosinophil differential count
|
HET
|
4f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.696
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NKT cell percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NKT cell percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / Effector CD4+ NKT cells - % of live leukocytes (Panel A)
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.00706
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / CD4 CD44+CD62L- NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Naive CD8+ T cells - % of CD8+
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector gd T cells - % of gd T cells
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Haematology / Mean cell volume
|
HET
|
8f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.731
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Haematology / Mean corpuscular haemoglobin
|
HET
|
8f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0519
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting gd T cells - % of gd T cells
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Plasmacytoid DC - % of DC
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Haematology / Mean cell haemoglobin concentration
|
HET
|
8f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.113
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / NKT Subsets (Q3)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Haematology / Platelets count
|
HET
|
8f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.460
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Cytotoxic T cell function / % lysis
|
WIL
|
6f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Cytotoxic T cell function / % lysis
|
HET
|
12f:12m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / DN CD25+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / Follicular B Cells (CD21/35+)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
FACS / T/NKT/B1
|
HET
|
4f:4m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / Follicular B cells - % of B cells (Panel B)
|
HET
|
7f:8m
|
|
|
NotProcessed |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Organ Weight / Spleen weight
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Organ Weight / Spleen weight
|
HET
|
f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD4- NKT cells - % of NKT cells
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD4+ T helper cells - % of CD4+
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Alpha beta T cell number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Alpha beta T cell number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Ly6C+ mature NK cells - % of mature NK cells
|
HET
|
1f:m
|
Supplied as data
|
1.00
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Vg5+ dendritic epidermal T cell (DETC) count
|
WIL
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Vg5+ dendritic epidermal T cell (DETC) count
|
HET
|
2f:1m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Follicular B cells - % of B2 cells
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Clow monocyte percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Clow monocyte percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
FACS / CD4 Resting/Naive
|
HET
|
4f:4m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ Treg cells - % of Treg
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / Resting CD4- NKT cells - % of live leukocytes (Panel A)
|
HET
|
7f:8m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / NKT cells (panel A)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / NKT cells (panel A)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / NKT cells (panel A) - % of live leukocytes (Panel A)
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0431
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
FACS / Spleen weight
|
HET
|
4f:4m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / B1B Cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / B1B Cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / DN CD44+CD62L+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Granulocytes - % of myeloid cells
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD4+ T helper cells - % of CD4+
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average volume of vg5+ DETC not contacting LC
|
WIL
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average volume of vg5+ DETC not contacting LC
|
HET
|
2f:1m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
FACS / cDC CD11b type
|
HET
|
4f:4m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Hematology / Hematocrit
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Hematology / Hematocrit
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0498
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Hematology / Hematocrit
|
HET
|
7f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.184
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Hematology / Hematocrit
|
HET
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.232
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Hematology / Hematocrit
|
HET
|
6f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.268
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Hematology / Hematocrit
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.371
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Hematology / Hematocrit
|
HET
|
7f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.376
|
Successful |
Nxnem1(IMPC)Bay
|
BCM
|
Hematology / Hematocrit
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.396
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Hematology / Hematocrit
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.460
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Hematocrit
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.498
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Hematology / Hematocrit
|
HET
|
5f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.549
|
Successful |
Nxnem1(IMPC)J
|
JAX
|
Hematology / Hematocrit
|
HET
|
5f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.678
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Hematology / Hematocrit
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.724
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Hematology / Hematocrit
|
HET
|
4f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.776
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Hematology / Hematocrit
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.860
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / NK Subsets (Q3)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Antigen Specific Immunoglobulin Assay / TetC specific total IgG
|
HET
|
2f:2m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / CD4- NKT cells - % of live leukocytes (Panel A)
|
HET
|
7f:8m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / DN NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / DN NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / CD11b- NK cells - % of live leukocytes (Panel B)
|
HET
|
7f:8m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Clow monocyte number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Clow monocyte number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ alpha beta T cell percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ alpha beta T cell percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average no of branches on vg5+ DETC not contacting LC
|
WIL
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average no of branches on vg5+ DETC not contacting LC
|
HET
|
2f:1m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
FACS / Tregs Resting
|
HET
|
4f:4m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD44+ CD62L- alpha beta effector T cell number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD44+ CD62L- alpha beta effector T cell number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD103+ CD11b-low cDC - % of CD11b-low cDC
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD4- NKT cells - % of NKT cells
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pro-B cells (Hardy fraction C) - % of B220+
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Myeloid cells - % of CD45+
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD4+ T helper cells - % of CD4+ T helper cells
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / CD4 CD44+CD62L- T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / KLRG1+ mature NK cell number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / KLRG1+ mature NK cell number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
FACS / NK Total
|
HET
|
4f:4m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / Effector CD4+ T helper cells - % of live leukocytes (Panel A)
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00765
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Germinal centre B cells - % of B2 cells
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / Effector CD8+ T cells - % of live leukocytes (Panel A)
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
1.13×10-07
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / CD8 CD44+CD62L- T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ Treg cells - % of Treg
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Marginal zone precursor B cells - % of B2 cells
|
HET
|
1f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / RP Macrophage (F4/80+)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4- NKT cells - % of CD4- NKT cells
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / Macrophages- % of live leukocytes (Panel B)
|
HET
|
7f:8m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Hematology / Large Unstained Cell (LUC) count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.132
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Large Unstained Cell (LUC) count
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.263
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Hematology / Large Unstained Cell (LUC) count
|
HET
|
7f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.662
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Plasmacytoid DC - % of DC
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Hematology / Lymphocyte cell count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.00102
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Hematology / Lymphocyte cell count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0254
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Hematology / Lymphocyte cell count
|
HET
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.103
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Hematology / Lymphocyte cell count
|
HET
|
4f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.173
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Lymphocyte cell count
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.443
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Hematology / Lymphocyte cell count
|
HET
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.651
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Hematology / Lymphocyte cell count
|
HET
|
7f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.689
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector NK cells - % of NK cells
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD103+ CD11b-low cDC - % of CD11b-low cDC
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
FACS / CD8 Resting
|
HET
|
4f:4m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / B cell percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / B cell percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total Treg cells - % of CD4+
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
FACS / B2 Total
|
HET
|
4f:4m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Hematology / Platelet count
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Hematology / Platelet count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0320
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Hematology / Platelet count
|
HET
|
7f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.121
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Hematology / Platelet count
|
HET
|
5f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.248
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Hematology / Platelet count
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.305
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Platelet count
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.316
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Hematology / Platelet count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.362
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Hematology / Platelet count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.390
|
Successful |
Nxnem1(IMPC)J
|
JAX
|
Hematology / Platelet count
|
HET
|
5f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.433
|
Successful |
Nxnem1(IMPC)Bay
|
BCM
|
Hematology / Platelet count
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.471
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Hematology / Platelet count
|
HET
|
4f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.644
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Hematology / Platelet count
|
HET
|
6f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.877
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Hematology / Platelet count
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.886
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Hematology / Platelet count
|
HET
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.907
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Hematology / Platelet count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.909
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD44+ CD62L- alpha beta effector T cell percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD44+ CD62L- alpha beta effector T cell percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
FACS / Macrophages
|
HET
|
4f:4m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / Monocytes
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / Monocytes
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
FACS / CD8 Naive
|
HET
|
4f:4m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / Monocytes - % of live leukocytes (Panel B)
|
HET
|
7f:8m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD4- NKT cells - % of CD4- NKT cells
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average roundness of vg5+ DETC not contacting LC
|
HET
|
2f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average roundness of vg5+ DETC not contacting LC
|
WIL
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / CD8 CD44+CD62L- NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Follicular B cells - % of B2 cells
|
HET
|
f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD4+ NKT cells - % of NKT cells
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Marginal zone precursor B cells - % of B2 cells
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Ly6C+ CD5+ T cells - % of CD5+ T cells
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ KLRG1+ alpha beta T cell number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ KLRG1+ alpha beta T cell number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Gamma delta T cell number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Gamma delta T cell number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average branch length of vg5+ DETC not contacting LC
|
HET
|
2f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average branch length of vg5+ DETC not contacting LC
|
WIL
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total DC - % of myeloid cells
|
HET
|
1f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / DN T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / T cells (panel B) - % of live leukocytes (Panel B)
|
HET
|
7f:8m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / T Cells (panel B)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / T Cells (panel B)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector gd T cells - % of gd T cells
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / Follicular B Cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ CD44+ CD62L- alpha beta effector T cell percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ CD44+ CD62L- alpha beta effector T cell percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average volume of LC
|
WIL
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average volume of LC
|
HET
|
2f:1m
|
Supplied as data
|
1.00
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average volume of LC
|
HET
|
2f:1m
|
Supplied as data
|
1.00
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD8+ T cells - % of CD8+
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Chigh monocyte number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Chigh monocyte number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Neutrophil percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Neutrophil percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / CD8 CD25- NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
FACS / CD4 Effector
|
HET
|
4f:4m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Macrophages - % of myeloid cells
|
HET
|
1f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Gamma delta T cell percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Gamma delta T cell percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / B1a cells - % of B cells
|
HET
|
1f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Hematology / Eosinophil cell count
|
HET
|
7f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0336
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Hematology / Eosinophil cell count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.209
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Hematology / Eosinophil cell count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.284
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Hematology / Eosinophil cell count
|
HET
|
8f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.286
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Hematology / Eosinophil cell count
|
HET
|
4f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.896
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Hematology / Eosinophil cell count
|
HET
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.944
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Eosinophil cell count
|
HET
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.975
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting NK cells - % of NK cells
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD5+ gd T cells - % of gd T cells
|
HET
|
1f:m
|
Supplied as data
|
1.00
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
FACS / Tregs
|
HET
|
4f:4m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / DN CD44+CD62L+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / cDCs
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / cDCs
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Hematology / Hemoglobin
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxnem1(IMPC)J
|
JAX
|
Hematology / Hemoglobin
|
HET
|
5f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.000149
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Hematology / Hemoglobin
|
HET
|
7f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00368
|
Successful |
Nxnem1(IMPC)Bay
|
BCM
|
Hematology / Hemoglobin
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0621
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Hematology / Hemoglobin
|
HET
|
5f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.227
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Hemoglobin
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.424
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Hematology / Hemoglobin
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.487
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Hematology / Hemoglobin
|
HET
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.574
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Hematology / Hemoglobin
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.645
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Hematology / Hemoglobin
|
HET
|
6f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.652
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Hematology / Hemoglobin
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.665
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Hematology / Hemoglobin
|
HET
|
7f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.805
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Hematology / Hemoglobin
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.969
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Hematology / Hemoglobin
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.987
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Hematology / Hemoglobin
|
HET
|
4f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.992
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / CD8 NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / Conventional DC - % of live leukocytes (Panel B)
|
HET
|
7f:8m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ alpha beta T cell percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ alpha beta T cell percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
FACS / DC Total
|
HET
|
4f:4m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD4+ T cells - % of ab T cells
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / Ly6C+ CD11b+ NK cells - % of live leukocytes (Panel B)
|
HET
|
7f:8m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Total T cell number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Total T cell number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / NK Subsets (Q2)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting gd T cells - % of gd T cells
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / MZB (CD21/35 high)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / DN CD44-CD62L+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / Marginal zone B cells - % of B cells (Panel B)
|
HET
|
7f:8m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average no of branches on vg5+ DETC contacting LC
|
WIL
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average no of branches on vg5+ DETC contacting LC
|
HET
|
2f:1m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / DN CD44-CD62L+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / NK cells (Panel A) - % of live leukocytes (Panel A)
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0192
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Haematology / White blood cell count
|
HET
|
8f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.464
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD4+ T helper cells - % of CD4+ T helper cells
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / KLRG1+ mature NK cell percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / KLRG1+ mature NK cell percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Haematology / Red blood cell count
|
HET
|
8f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.118
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Haematology / Haemoglobin
|
HET
|
8f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.466
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / NK cells (panel A)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / NK cells (panel A)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Haematology / Haematocrit
|
HET
|
8f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.234
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD11b-low cDC - % of cDC
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / B2B Cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / B2B Cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pre-B cells (Hardy fraction D) - % of B220+
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total B cells - % of CD45+
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Ly6C+ NKT cells - % of NKT cells
|
HET
|
1f:m
|
Supplied as data
|
1.00
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD4+ NKT cells - % of CD4+ NKT cells
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / CD8 CD25+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Hematology / Neutrophil differential count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0406
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Hematology / Neutrophil differential count
|
HET
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0870
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Hematology / Neutrophil differential count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.393
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Hematology / Neutrophil differential count
|
HET
|
7f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.440
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Hematology / Neutrophil differential count
|
HET
|
4f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.445
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Hematology / Neutrophil differential count
|
HET
|
8f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.486
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Neutrophil differential count
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.864
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / CD8 CD44+CD62L+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average volume of vg5+ DETC
|
HET
|
2f:1m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average volume of vg5+ DETC
|
WIL
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ KLRG1+ alpha beta T cell number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ KLRG1+ alpha beta T cell number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / IgD+ mature B cell percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Eosinophils - % of myeloid cells
|
HET
|
1f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / Ly6C+ NKT cells - % of live leukocytes (Panel B)
|
HET
|
7f:8m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / NKT Subsets (Q1)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Granulocytes - % of CD45+
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD8+ T cells - % of ab T cells
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / CD8 CD25+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD4+ NKT cells - % of CD4+ NKT cells
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total NK cells - % of CD45+
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Immunoglobulin / IgG1
|
HET
|
2f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
FACS / NKT Effector
|
HET
|
4f:4m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / Naïve CD8+ T cells - % of live leukocytes (Panel A)
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.490
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / CD8 CD44+CD62L+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / RP Macrophage (CD19- CD11c-)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Immunoglobulin / IgG3
|
HET
|
2f:m
|
|
|
NotProcessed |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Hematology / Lymphocyte differential count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0776
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Hematology / Lymphocyte differential count
|
HET
|
7f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.163
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Hematology / Lymphocyte differential count
|
HET
|
8f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.240
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Hematology / Lymphocyte differential count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.435
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Hematology / Lymphocyte differential count
|
HET
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.455
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Lymphocyte differential count
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.694
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Hematology / Lymphocyte differential count
|
HET
|
4f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.892
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Immunoglobulin / IgG2b
|
HET
|
3f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total DC - % of myeloid cells
|
HET
|
1f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
FACS / Neutrophils
|
HET
|
4f:4m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / Granulocytes - % of live leukocytes (Panel B)
|
HET
|
7f:8m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Immunoglobulin / IgE
|
HET
|
6f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.501
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Immunoglobulin / IgA
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Mature NK cells - % of NK cellls
|
HET
|
1f:m
|
Supplied as data
|
1.00
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD8+ T cells - % of CD8+
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Transitional 2 B cells - % of B2 cells
|
HET
|
1f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / CD4 CD44-CD62L+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / Neutrophils
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / Neutrophils
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting NK cells - % of NK cells
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Hematology / Monocyte differential count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0781
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Monocyte differential count
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.161
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Hematology / Monocyte differential count
|
HET
|
4f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.228
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Hematology / Monocyte differential count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.287
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Hematology / Monocyte differential count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.469
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Hematology / Monocyte differential count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.729
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Hematology / Monocyte differential count
|
HET
|
7f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.861
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
FACS / NKT Resting
|
HET
|
4f:4m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / Resting CD8+ T cells - % of live leukocytes (Panel A)
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.306
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / CD8 CD44-CD62L+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / DN CD25+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total gd T cells - % of total T cells
|
HET
|
1f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ alpha beta T cell number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ alpha beta T cell number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Plasma cells - % of CD45+
|
HET
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD25+ alpha beta regulatory T cell percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD25+ alpha beta regulatory T cell percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / Transitional B Cells (CD21/35 low)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
FACS / CD8 Effector
|
HET
|
4f:4m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD4- NKT cells - % of CD4- NKT cells
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting Treg cells - % of Treg
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Transitional 1 B cells - % of B2 cells
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Monocyte percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Monocyte percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
FACS / Total cell count in spleen
|
HET
|
4f:4m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD4+ T helper cells - % of CD4+ T helper cells
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Monocyte number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Monocyte number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total ab T cells - % of total T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Antigen Specific Immunoglobulin Assay / TetC specific IgG1
|
HET
|
2f:2m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Salmonella Challenge / Pre-Day 14 Death
|
HET
|
2f:2m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average branch length of LC
|
WIL
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average branch length of LC
|
HET
|
2f:m
|
Supplied as data
|
1.00
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average branch length of LC
|
HET
|
2f:m
|
Supplied as data
|
1.00
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector NK cells - % of NK cells
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
FACS / Tregs Effector
|
HET
|
4f:4m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / Ly6C+ CD11b- NK cells - % of live leukocytes (Panel B)
|
HET
|
7f:8m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
FACS / B1 Total
|
HET
|
4f:4m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting Treg cells - % of Treg
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / CD4+ NKT cells - % of live leukocytes (Panel A)
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.00606
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / CD4 NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total gd T cells - % of total T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / NK Subsets (Q1)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Pre-Day 10 Death
|
HET
|
2f:2m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average roundness of vg5+ DETC
|
WIL
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average roundness of vg5+ DETC
|
HET
|
2f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Hematology / Mean cell volume
|
HET
|
7f:7m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Hematology / Mean cell volume
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Hematology / Mean cell volume
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.000104
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Hematology / Mean cell volume
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00148
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Mean cell volume
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0170
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Hematology / Mean cell volume
|
HET
|
4f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0367
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Hematology / Mean cell volume
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0416
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Hematology / Mean cell volume
|
HET
|
7f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.268
|
Successful |
Nxnem1(IMPC)J
|
JAX
|
Hematology / Mean cell volume
|
HET
|
5f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.279
|
Successful |
Nxnem1(IMPC)Bay
|
BCM
|
Hematology / Mean cell volume
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.283
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Hematology / Mean cell volume
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.299
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Hematology / Mean cell volume
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.338
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Hematology / Mean cell volume
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.525
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Hematology / Mean cell volume
|
HET
|
5f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.825
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Hematology / Mean cell volume
|
HET
|
6f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.964
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average no of branches on vg5+ DETC
|
HET
|
2f:1m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average no of branches on vg5+ DETC
|
WIL
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Eosinophil number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Eosinophil number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Germinal centre B cells - % of B2 cells
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD4+ T helper cells - % of CD4+ T helper cells
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD8+ T cells - % of CD8+
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD4+ NKT cells - % of CD4+ NKT cells
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total myeloid cells - % of CD45+
|
HET
|
1f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
FACS / gd + B1
|
HET
|
4f:4m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Immature B cells (Hardy fraction E) - % of B220+
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Eosinophil percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Eosinophil percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total ab T cells - % of total T cells
|
HET
|
1f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Basophil cell count
|
HET
|
7f:7m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Hematology / Basophil cell count
|
HET
|
8f:8m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Hematology / Basophil cell count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0332
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Hematology / Basophil cell count
|
HET
|
7f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.194
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Hematology / Basophil cell count
|
HET
|
4f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.899
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Hematology / Basophil cell count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.975
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Hematology / Basophil cell count
|
HET
|
8f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.995
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
FACs Analysis / T cell CD8+ percentage
|
HET
|
5f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.551
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total B2 cells - % of B cells
|
HET
|
1f:3m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
FACs Analysis / T cell CD4+ percentage
|
HET
|
5f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.112
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD11b-high cDC - % of cDC
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
FACS / Eosinophils
|
HET
|
4f:4m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Hematology / Red blood cell count
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Hematology / Red blood cell count
|
HET
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0450
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Hematology / Red blood cell count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.289
|
Successful |
Nxnem1(IMPC)Bay
|
BCM
|
Hematology / Red blood cell count
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.300
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Hematology / Red blood cell count
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.396
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Hematology / Red blood cell count
|
HET
|
6f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.641
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Hematology / Red blood cell count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.657
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Hematology / Red blood cell count
|
HET
|
4f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.684
|
Successful |
Nxnem1(IMPC)J
|
JAX
|
Hematology / Red blood cell count
|
HET
|
5f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.685
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Hematology / Red blood cell count
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.764
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Hematology / Red blood cell count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.785
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Hematology / Red blood cell count
|
HET
|
5f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.811
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Hematology / Red blood cell count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.837
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Hematology / Red blood cell count
|
HET
|
7f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.902
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Red blood cell count
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.953
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total NKT cells - % of CD45+
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Clinical Chemistry / LIH (Hemolysis Severity - available on AU analysers)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Clinical Chemistry / LIH (Hemolysis Severity - available on AU analysers)
|
HET
|
8f:7m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / LIH (Hemolysis Severity - available on AU analysers)
|
HET
|
8f:7m
|
|
|
NotProcessed |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Clinical Chemistry / LIH (Hemolysis Severity - available on AU analysers)
|
HET
|
8f:8m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Clinical Chemistry / LIH (Hemolysis Severity - available on AU analysers)
|
HET
|
8f:8m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / LIH (Hemolysis Severity - available on AU analysers)
|
HET
|
9f:8m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / LIH (Hemolysis Severity - available on AU analysers)
|
HET
|
8f:8m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / cDCs CD11b Type
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / cDCs CD11b Type
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / CD4 CD44-CD62L+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ gd T cells - % of gd T cells
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / MZB
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ KLRG1+ alpha beta T cell percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ KLRG1+ alpha beta T cell percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD11b-high cDC - % of cDC
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / NKT cells (panel B) - % of live leukocytes (Panel B)
|
HET
|
7f:8m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4+ NKT cells - % of CD4+ NKT cells
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / CD4+ T helper cells - % of live leukocytes (Panel A)
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0273
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / CD4 CD25- T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / B1a cells - % of B cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
FACS / B2 Mature
|
HET
|
4f:4m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / NKT Cells (panel B)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / NKT Cells (panel B)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Hematology / Neutrophil cell count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.106
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Hematology / Neutrophil cell count
|
HET
|
8f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.114
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Hematology / Neutrophil cell count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.137
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Hematology / Neutrophil cell count
|
HET
|
7f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.229
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Hematology / Neutrophil cell count
|
HET
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.270
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Hematology / Neutrophil cell count
|
HET
|
4f:3m
|
Linear Mixed Model framework, LME, including Weight
|
0.305
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Neutrophil cell count
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.748
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Eosinophils - % of myeloid cells
|
HET
|
1f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / CD8 CD44-CD62L+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / T Subset
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Ly6C+ immature NK cells - % of immature NK cells
|
HET
|
1f:m
|
Supplied as data
|
1.00
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD8+ T cells - % of CD8+
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD4+ NKT cells - % of CD4+ NKT cells
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average branch length of vg5+ DETC
|
WIL
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average branch length of vg5+ DETC
|
HET
|
2f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector Treg cells - % of Treg
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Trichuris / Presence of worms in caecum
|
HET
|
6f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pro-B cells (Hardy fractions B and C) - % of B220+
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Monocytes - % of myeloid cells
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Total B cells - % of CD45+
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NK cell number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NK cell number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Total T cell percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Total T cell percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Organ Weight / Thymus weight
|
HET
|
f:2m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD8+ T cells - % of CD8+
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD5+ gd T cells - % of gd T cells
|
HET
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Average histology score
|
HET
|
2f:2m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Conventional DC (cDC) - % of DC
|
HET
|
1f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Chigh monocyte percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Chigh monocyte percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
FACS / NKT Total
|
HET
|
4f:4m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / Transitional B Cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD4- NKT cells - % of CD4- NKT cells
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector Treg cells - % of Treg
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Organ Weight / Spleen weight
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0731
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Anti-nuclear antibody assay / ANA classification
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Anti-nuclear antibody assay / ANA classification
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Trichuris / Pre day 32 death
|
HET
|
6f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ NK cells - % of NK cells
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Hematology / Monocyte cell count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.00963
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Hematology / Monocyte cell count
|
HET
|
4f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0420
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Monocyte cell count
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.365
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Hematology / Monocyte cell count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.435
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Hematology / Monocyte cell count
|
HET
|
7f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.671
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Hematology / Monocyte cell count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.698
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Hematology / Monocyte cell count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.859
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NK cell percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NK cell percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Immature NK cells - % of NK cells
|
HET
|
1f:m
|
Supplied as data
|
1.00
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ alpha beta T cell number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ alpha beta T cell number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total NKT cells - % of CD45+
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total NK cells - % of CD45+
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / NK Cells (panel B)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / NK Cells (panel B)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / DN CD25- T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
FACS / B cell total
|
HET
|
4f:4m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / NK cells (Panel B) - % of live leukocytes (Panel B)
|
HET
|
7f:8m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD4+ T cells - % of ab T cells
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Hematology / Mean corpuscular hemoglobin
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Hematology / Mean corpuscular hemoglobin
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.000314
|
Successful |
Nxnem1(IMPC)J
|
JAX
|
Hematology / Mean corpuscular hemoglobin
|
HET
|
5f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00110
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Hematology / Mean corpuscular hemoglobin
|
HET
|
5f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0208
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Mean corpuscular hemoglobin
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0462
|
Successful |
Nxnem1(IMPC)Bay
|
BCM
|
Hematology / Mean corpuscular hemoglobin
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0672
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Hematology / Mean corpuscular hemoglobin
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.304
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Hematology / Mean corpuscular hemoglobin
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.361
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Hematology / Mean corpuscular hemoglobin
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.442
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Hematology / Mean corpuscular hemoglobin
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.484
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Hematology / Mean corpuscular hemoglobin
|
HET
|
4f:3m
|
Linear Mixed Model framework, LME, including Weight
|
0.649
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Hematology / Mean corpuscular hemoglobin
|
HET
|
6f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.655
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Hematology / Mean corpuscular hemoglobin
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.691
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Hematology / Mean corpuscular hemoglobin
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.734
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Hematology / Mean corpuscular hemoglobin
|
HET
|
7f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.938
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
FACs Analysis / Number of leukocytes
|
HET
|
4f:2m
|
Linear Mixed Model framework, LME, not including Weight
|
0.372
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Transitional 2 B cells - % of B2 cells
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
FACS / pDCs
|
HET
|
4f:4m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
FACS / CD4 T cells total
|
HET
|
4f:4m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Large Unstained Cell (LUC) differential count
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0298
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Hematology / Large Unstained Cell (LUC) differential count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0757
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Hematology / Large Unstained Cell (LUC) differential count
|
HET
|
7f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.329
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
FACs Analysis / NK cell percentage
|
HET
|
5f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.953
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / IgD+ mature B cell number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / IgD+ mature B cell number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average roundness of LC
|
WIL
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average roundness of LC
|
HET
|
2f:m
|
Supplied as data
|
1.00
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average roundness of LC
|
HET
|
2f:m
|
Supplied as data
|
1.00
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
FACs Analysis / Granulocyte Gr1+ percentage
|
HET
|
5f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.316
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
FACs Analysis / Monocyte gate
|
HET
|
5f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.467
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / CD4 CD44+CD62L+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
FACs Analysis / CD25+ percentage of CD4+ T cells
|
HET
|
5f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.148
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
FACs Analysis / T cell CD3+ percentage
|
HET
|
5f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0365
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
FACs Analysis / Mature B cells IgD+ percentage
|
HET
|
5f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0775
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD4+ T helper cells - % of CD4+ T helper cells
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / Resting CD4+ NKT cells - % of live leukocytes (Panel A)
|
HET
|
7f:8m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
FACs Analysis / B cell CD19+ percentage
|
HET
|
5f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0185
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / T cells - % of CD45+
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Mature B cells (Hardy fraction F) - % of B220+
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Conventional DC (cDC) - % of DC
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / CD4 T cells - % of live leukocytes (Panel A)
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0324
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / CD4 T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Transitional 1 B cells - % of B2 cells
|
HET
|
1f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ gd T cells - % of gd T cells
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / Basophil differential count
|
HET
|
7f:7m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Hematology / Basophil differential count
|
HET
|
8f:8m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Hematology / Basophil differential count
|
HET
|
7f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.447
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Hematology / Basophil differential count
|
HET
|
8f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.754
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Hematology / Basophil differential count
|
HET
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.843
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Hematology / Basophil differential count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.843
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Hematology / Basophil differential count
|
HET
|
4f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.851
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average volume of vg5+ DETC contacting LC
|
HET
|
2f:1m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average volume of vg5+ DETC contacting LC
|
WIL
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Neutrophil number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Neutrophil number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ KLRG1+ alpha beta T cell percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ KLRG1+ alpha beta T cell percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD4+ NKT cells - % of CD4+ NKT cells
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ CD44+ CD62L- alpha beta effector T cell number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ CD44+ CD62L- alpha beta effector T cell number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD8+ T cells - % of CD8+
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Macrophages - % of myeloid cells
|
HET
|
1f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
FACS / iNKT
|
HET
|
4f:4m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / CD11b+ NK cells - % of live leukocytes (Panel B)
|
HET
|
7f:8m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / NK Subsets (Q4)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Monocytes - % of myeloid cells
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Marginal zone B cells - % of B2 cells
|
HET
|
1f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / Plasmacytoid DC- % of live leukocytes (Panel B)
|
HET
|
7f:8m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD8+ T cells - % of ab T cells
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / pDCs
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Hematology / Red blood cell distribution width
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.000121
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Hematology / Red blood cell distribution width
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0424
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Hematology / Red blood cell distribution width
|
HET
|
5f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.131
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Hematology / Red blood cell distribution width
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.142
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Hematology / Red blood cell distribution width
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.216
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Hematology / Red blood cell distribution width
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.307
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Hematology / Red blood cell distribution width
|
HET
|
7f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.799
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Hematology / Red blood cell distribution width
|
HET
|
4f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.817
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
FACS / CD8 T cells total
|
HET
|
4f:4m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Langerhans cell (LC) count
|
WIL
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Langerhans cell (LC) count
|
HET
|
2f:1m
|
Supplied as data
|
1.00
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Langerhans cell (LC) count
|
HET
|
2f:1m
|
Supplied as data
|
1.00
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
FACS / cDC CD8a type
|
HET
|
4f:4m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / CD4 CD25+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / Treg cells - % of live leukocytes (Panel A)
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.140
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Alpha beta T cell percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Alpha beta T cell percentage
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average no of branches on LC
|
WIL
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average no of branches on LC
|
HET
|
2f:1m
|
Supplied as data
|
1.00
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average no of branches on LC
|
HET
|
2f:1m
|
Supplied as data
|
1.00
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD25+ alpha beta regulatory T cell number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD25+ alpha beta regulatory T cell number
|
HET
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / Resting CD4+ T helper cells - % of live leukocytes (Panel A)
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.696
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD4- NKT cells - % of CD4- NKT cells
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Clinical Chemistry / Glycosilated hemoglobin A1c (HbA1c)
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.863
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pro-B cells (Hardy fraction B) - % of B220+
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD11b-low cDC - % of cDC
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / T cells (Panel A) - % of live leukocytes (Panel A)
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.00619
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / CD4 CD44+CD62L+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total B2 cells - % of B cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / B cells - % of live leukocytes (Panel B)
|
HET
|
7f:8m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / T cells (panel A)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total T cells - % of CD45+
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Immunophenotyping / B Cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / B Cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / DN CD44+CD62L- NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total Treg cells - % of CD4+
|
HET
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Immunophenotyping / Effector CD4- NKT cells - % of live leukocytes (Panel A)
|
HET
|
7f:8m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Immunophenotyping / CD4 CD25+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Hematology / White blood cell count
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Hematology / White blood cell count
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.00161
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Hematology / White blood cell count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0123
|
Successful |
Nxnem1(IMPC)Bay
|
BCM
|
Hematology / White blood cell count
|
HET
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0435
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Hematology / White blood cell count
|
HET
|
5f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.188
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Hematology / White blood cell count
|
HET
|
4f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.192
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Hematology / White blood cell count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.228
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Hematology / White blood cell count
|
HET
|
6f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.252
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Hematology / White blood cell count
|
HET
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.314
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Hematology / White blood cell count
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.428
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Hematology / White blood cell count
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.605
|
Successful |
Nxnem1(IMPC)J
|
JAX
|
Hematology / White blood cell count
|
HET
|
5f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.748
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Hematology / White blood cell count
|
HET
|
7f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.761
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Hematology / White blood cell count
|
HET
|
7f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.847
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Hematology / White blood cell count
|
HET
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.992
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD4+ NKT cells - % of NKT cells
|
HET
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |